Brief: Abionyx Pharma Cash And Cash Equivalents Of EUR 8.2 Mln As Of September 30, 2020

Abionyx Pharma SA

22/10/2020 17:52

Oct 22 (Reuters) - Abionyx Pharma SA  ABNX.PA :
    * CASH AND CASH EQUIVALENTS OF EUR 8.2 MILLION AS OF
SEPTEMBER 30,
2020
    * IS PURSUING DISCUSSIONS WITH REGULATORY AGENCIES FOR
APPROVAL TO
PROCEED WITH AN IN VIVO STUDY ON MECHANISM OF ACTION OF CER-001
    * WILL PROCEED TO PREPAYMENT OF RAW MATERIALS FOR
APPROXIMATELY
EUR 2 MILLION, IN ORDER TO SECURE ITS SUPPLY CHAIN AND
TECHNOLOGY TRANSFER DELAYS FOR A RELOCATION OF ITS PRODUCTION IN
FRANCE.

Source text for Eikon:  ID:nNDL9vqzpk 
Further company coverage:  ABNX.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))